Oxford Biomedica (OXBDF) News Today $5.35 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Oxford Biomedica Announces Total Voting RightsDecember 2, 2024 | markets.businessinsider.comOxford Biomedica Aligns Executive Incentives with GoalsNovember 23, 2024 | markets.businessinsider.comOxford Biomedica price target raised to 450 GBp from 305 GBp at JPMorganOctober 29, 2024 | markets.businessinsider.comOxford Biomedica Seeks Stock Market ExpansionOctober 22, 2024 | markets.businessinsider.comShort Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Drops By 66.7%Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report) was the target of a large decrease in short interest in September. As of September 30th, there was short interest totalling 100 shares, a decrease of 66.7% from the September 15th total of 300 shares. Based on an average daily trading volume, of 5,600 shares, the short-interest ratio is currently 0.0 days.October 10, 2024 | marketbeat.comRBC Capital Sticks to Its Buy Rating for Oxford BioMedica (OXBDF)September 27, 2024 | markets.businessinsider.comOxford BioMedica: A Strong Buy on Undervaluation and Promising Growth ProspectsSeptember 24, 2024 | markets.businessinsider.comOxford Biomedica posts strong revenue growth in first half resultsSeptember 23, 2024 | msn.comOxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMOSeptember 18, 2024 | globenewswire.comLucinda Crabtree joins Oxford Biomedica as Chief Financial Officer todaySeptember 2, 2024 | globenewswire.comOxford Biomedica plc (OXBDF)August 18, 2024 | finance.yahoo.comOxford Biomedica – Half Year Trading Update and Notice of Interim ResultsAugust 8, 2024 | markets.businessinsider.comOxford Biomedica announces CFO transitionJuly 17, 2024 | globenewswire.comOxford Biomedica Full Year 2023 Earnings: Misses ExpectationsMay 1, 2024 | finance.yahoo.comOxford Biomedica plc GAAP EPS of -163.11p, revenue of £89.5MApril 30, 2024 | msn.comSMALL-CAP WINNERS & LOSERS: Oxford BioMedica bullish; Petrofac slumpsApril 29, 2024 | lse.co.ukOxford BioMedica PLCApril 20, 2024 | barrons.comOxford Biomedica Insiders Placed Bullish Bets Worth UK£415.3kMarch 30, 2024 | finance.yahoo.comOxford BioMedica PLC (OXB)January 23, 2024 | investing.comOxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturingJanuary 23, 2024 | finance.yahoo.comOxford BioMedica PLC OXOANovember 5, 2023 | morningstar.comAnalysts Just Slashed Their Oxford Biomedica plc (LON:OXB) EPS NumbersSeptember 25, 2023 | finance.yahoo.comOxford Biomedica (OTCMKTS:OXBDF) Price Target Cut to GBX 325 by Analysts at JPMorgan Chase & Co.JPMorgan Chase & Co. cut their price objective on Oxford Biomedica from GBX 495 ($6.13) to GBX 325 ($4.03) in a research report on Friday.September 22, 2023 | marketbeat.comOxford BioMedica shares boom as manufacturer expands complex cancer therapiesSeptember 21, 2023 | msn.comOxford BioMedica shares up, in talks to buy ABL Europe but loss widensSeptember 20, 2023 | lse.co.ukOxford Biomedica stock soars on rosy forecast, talks to buy ABL EuropeSeptember 20, 2023 | msn.comOxford BioMedica Shares Rise on Transformational Deal Talks, Revenue Growth ExpectationSeptember 20, 2023 | marketwatch.comOxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux as part of pure-play CDMO transformationSeptember 20, 2023 | finance.yahoo.comKyverna Therapeutics and Oxford Biomedica Sign License and Supply Agreement for LentiVector® PlatformSeptember 20, 2023 | finance.yahoo.comOxford Biomedica to host webinar showcasing the TetraVecta™ systemSeptember 7, 2023 | finance.yahoo.comOxford Biomedica (LON:OXB) shareholders have endured a 50% loss from investing in the stock five years agoJuly 10, 2023 | finance.yahoo.comOxford BioMedica's Executive Pay Report Gets Low Shareholder Support at Annual MeetingJune 23, 2023 | marketwatch.comDr Frank Mathias to join Oxford Biomedica as new CEO on 27 March 2023February 20, 2023 | finance.yahoo.comThe past year for Oxford Biomedica (LON:OXB) investors has not been profitableJanuary 30, 2023 | finance.yahoo.comOxford Biomedica to complete sale and leaseback of Windrush Court facility for £60 millionNovember 14, 2022 | finance.yahoo.comOxford BioMedica swings to interim loss as costs climb, revenue fallsSeptember 15, 2022 | lse.co.ukOxford Biomedica (LON:OXB) shareholders have endured a 66% loss from investing in the stock a year agoAugust 19, 2022 | finance.yahoo.comOxford BioMedica begins new project and signs license agreementJuly 26, 2022 | lse.co.ukOxford Biomedica Signs Licence & Supply Agreement with New Partner for LentiVector® Platform for CAR-T TherapyJuly 26, 2022 | finance.yahoo.comOxford Biomedica plc's (LON:OXB) Intrinsic Value Is Potentially 20% Below Its Share PriceJuly 16, 2022 | finance.yahoo.comSMALL-CAP WINNERS & LOSERS: Oxford BioMedica rises on AstraZeneca dealJuly 1, 2022 | lse.co.ukAstraZeneca signs new three-year deal with Oxford Biomedica for COVID shotJuly 1, 2022 | seekingalpha.comOxford BioMedica extends Covid vaccine deal with AstraZenecaJuly 1, 2022 | finance.yahoo.comUS FDA lifts clinical hold on Oxford BioMedica partner's trialJune 14, 2022 | lse.co.ukCould The Market Be Wrong About Oxford Biomedica plc (LON:OXB) Given Its Attractive Financial Prospects?May 15, 2022 | finance.yahoo.comOxford Biomedica reports 63% revenue growth linked to AstraZeneca vaccine supply: PrelimApril 20, 2022 | seekingalpha.comOxford BioMedica shares fall as warns on 2022 amid Covid jab pauseApril 20, 2022 | lse.co.ukOxford BioMedica Sees Lower 2022 Revenue on Suspension of Covid-19 Vaccine With AstraZenecaApril 20, 2022 | marketwatch.comOxford BioMedica warns revenue will be hit by AstraZeneca jab uncertaintyApril 20, 2022 | ft.comOxford Biomedica warns on sales after pausing AstraZeneca COVID vaccineApril 20, 2022 | uk.finance.yahoo.com Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter. Email Address First JFK… next Elon? (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger. I share with you in this special investigative documentary. OXBDF Media Mentions By Week OXBDF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXBDF News Sentiment▼0.000.60▲Average Medical News Sentiment OXBDF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXBDF Articles This Week▼00▲OXBDF Articles Average Week Get Oxford Biomedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PRPPF News NPSKY News OERLF News OMVKY News OSAGF News OUTKY News PYPTF News PGENY News PXXLF News RAIFY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OXBDF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford Biomedica plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford Biomedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
